EMA — authorised 15 September 2022
- Marketing authorisation holder: ROCHE REGISTRATION GMBH
- Status: approved
EMA authorised Vabysmo on 15 September 2022
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 15 September 2022.
ROCHE REGISTRATION GMBH holds the EU marketing authorisation.